Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations
Abstract
Background: Short-term forecasts of infectious disease contribute to situational awareness and capacity planning. Based on best practice in other fields and recent insights in infectious disease epidemiology, one can maximise forecasts’ predictive performance by combining independent models into an ensemble. Here we report the performance of ensemble predictions of COVID-19 cases and deaths across Europe from March 2021 to March 2022.
Methods: We created the European COVID-19 Forecast Hub, an online open-access platform where modellers upload weekly forecasts for 32 countries with results publicly visualised and evaluated. We created a weekly ensemble forecast from the equally-weighted average across individual models' predictive quantiles. We measured forecast accuracy using a baseline and relative Weighted Interval Score (rWIS). We retrospectively explored ensemble methods, including weighting by past performance.
Results: We collected weekly forecasts from 48 models, of which we evaluated 29 models alongside the ensemble model. The ensemble had a consistently strong performance across countries over time, performing better on rWIS than 91% of forecasts for deaths (N=763 predictions from 20 models), and 83% forecasts for cases (N=886 predictions from 23 models). Performance remained stable over a 4-week horizon for death forecasts but declined with longer horizons for cases. Among ensemble methods, the most influential choice came from using a median average instead of the mean, regardless of weighting component models.
Conclusions: Our results support combining independent models into an ensemble forecast to improve epidemiological predictions, and suggest that median averages yield better performance than methods based on means. We highlight that forecast consumers should place more weight on incident death forecasts than case forecasts at horizons greater than two weeks.
Funding: European Commission, Ministerio de Ciencia, Innovación y Universidades, FEDER; Agència de Qualitat i Avaluació Sanitàries de Catalunya; Netzwerk Universitätsmedizin; Health Protection Research Unit; Wellcome Trust; European Centre for Disease Prevention and Control; Ministry of Science and Higher Education of Poland; Federal Ministry of Education and Research; Los Alamos National Laboratory; German Free State of Saxony; NCBiR; FISR 2020 Covid-19 I Fase; Spanish Ministry of Health / REACT-UE (FEDER); National Institutes of General Medical Sciences; Ministerio de Sanidad/ISCIII; PERISCOPE European H2020; PERISCOPE European H2021; InPresa; National Institutes of Health, NSF, US Centers for Disease Control and Prevention, Google, University of Virginia, Defense Threat Reduction Agency.
Data availability
All source data were openly available before the study, originally available at: https://github.com/covid19-forecast-hub-europe/covid19-forecast-hub-europe. All data and code for this study are openly available on Github: covid19-forecast-hub-europe/euro-hub-ensemble.
Article and author information
Author details
Funding
NUM (Netzwerk Universitätsmedizin (NUM) project egePan (01KX2021))
- Jonas Dehning
- Sebastian Mohr
- Viola Priesemann
MUNI (Mathematical and Statistical modelling project (MUNI/A/1615/2020),MUNI/11/02202001/2020)
- Veronika Eclerová
- Lenka Pribylova
Ministerio de Sanidad/ISCIII
- Cesar Pérez Álvarez
- Borja Reina
- Jose L Aznarte
Ministry of Science and Higher Education of Poland (28/WFSN/2021)
- Rafal P Bartczuk
- Filip Dreger
- Magdalena Gruziel-Słomka
- Bartosz Krupa
- Antoni Moszyński
- Karol Niedzielewski
- Jedrzej Nowosielski
- Maciej Radwan
- Franciszek Rakowski
- Marcin Semeniuk
- Jakub Zieliński
- Jan Kisielewski
National Institutes of General Medical Sciences (R35GM119582)
- Graham Gibson
- Evan L Ray
- Nicholas G Reich
- Daniel Sheldon
- Yijin Wang
- Nutcha Wattanachit
FISR (SMIGE - Modelli statistici inferenziali per governare l'epidemia,FISR 2020 - Covid-19 I Fase,FISR2020IP_00156,Codice Progetto - PRJ-0695)
- Antonello Maruotti
- Gianfranco Lovison
- Alessio Farcomeni
AQuAS (Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) through contract 2021_021OE)
- Inmaculada Villanueva
European Centre for Disease Prevention and Control
- Katharine Sherratt
- Hugo Gruson
European Commission (Communications Networks Content and Technology LC-01485746,Ministerio CIU/FEDER PGC2018-095456-B-I00)
- Sergio Alonso
- Enric Álvarez
- Daniel López
- Clara Prats
BMBF (Federal Ministry of Education and Research (BMBF; grant 05M18SIA))
- Stefan Heyder
- Thomas Hotz
- Jan Pablo Burgard
Health Protection Research Unit (NIHR200908)
- Nikos I Bosse
InPresa (Lombardy Region Italy)
- Fulvia Pennoni
- Francesco Bartolucci
LANL (Laboratory Directed Research and Development program of Los Alamos National Laboratory (LANL) under)
- Lauren Castro
- Geoffrey Fairchild
- Isaac Michaud
- Dave Osthus
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Metrics
-
- 2,102
- views
-
- 309
- downloads
-
- 34
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Epidemiology and Global Health
- Genetics and Genomics
Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.
-
- Epidemiology and Global Health
Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.